Nanotech, Single-Molecule Methods, Personalized Medicine Remain Top of Mind for VCs (GenomeWeb News)
This is part two of a two-part series examining the venture capital landscape in the life science research tools and molecular diagnostics markets. To read part one, click here .
(more…)